Skip to content
Home/Companies/Healthcare/BIOGEMMA

BIOGEMMA

Healthcare·France·Exited 2018·Held 2yr
Entry
2016
Hold
2yr
Exit
2018

Who owns BIOGEMMA?

BIOGEMMA was owned by Unigrains through Unigrains Capital Investissement Direct (2010 vintage) from 2016 to 2018, exited via MBO.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Unigrains
Investor
Unigrains
Unigrains Capital Investissement Direct · 2010 · Buyout

Key facts

HQFrance
SectorHealthcare
Exit Type
MBO
Buyer
MOIC
–
Exit Year
2018

More from Unigrains Capital Investissement Direct

Other portfolio companies in the same fund.

IRRIFRANCE Groupe
IRRIFRANCE Groupe
Active
· 2025
L'Albero del Pane
L'Albero del Pane
Active
· 2025
LIM Group
Active
IndustrialsFrance· 2025
Sicavyl Sica DE Viandes DE L Yonne ET DU Loiret
Active
Business ServicesFrance· 2025
Staphyt
Staphyt
Active
· 2025
Demarne
Demarne
Active
ConsumerFrance· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Biogemma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Biogemma?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Biogemma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue